Compare KRYS & IDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KRYS | IDA |
|---|---|---|
| Founded | 2015 | 1915 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 7.0B |
| IPO Year | 2017 | N/A |
| Metric | KRYS | IDA |
|---|---|---|
| Price | $241.84 | $125.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $214.22 | $133.00 |
| AVG Volume (30 Days) | 286.6K | ★ 395.1K |
| Earning Date | 11-03-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 2.80% |
| EPS Growth | ★ 275.72 | 7.17 |
| EPS | ★ 6.66 | 5.84 |
| Revenue | $373,164,000.00 | ★ $1,805,885,000.00 |
| Revenue This Year | $36.14 | $6.64 |
| Revenue Next Year | $41.80 | $7.70 |
| P/E Ratio | $36.72 | ★ $21.55 |
| Revenue Growth | ★ 54.51 | N/A |
| 52 Week Low | $122.80 | $104.74 |
| 52 Week High | $248.60 | $138.03 |
| Indicator | KRYS | IDA |
|---|---|---|
| Relative Strength Index (RSI) | 74.92 | 40.49 |
| Support Level | $213.83 | $124.84 |
| Resistance Level | $248.60 | $127.42 |
| Average True Range (ATR) | 7.44 | 2.12 |
| MACD | 1.29 | -0.09 |
| Stochastic Oscillator | 78.92 | 19.83 |
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The companys only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education.